FDA: Firms’ Fresh Look At Procedures Contributed To MDR Increase In ’07
This article was originally published in The Gray Sheet
Executive Summary
A number of manufacturers reappraising their complaint handling procedures contributed to an unprecedented upsurge in adverse events reported last year under FDA's Medical Device Reporting (MDR) program, an agency official says